TY  - JOUR
AU  - Genescà, E
AU  - Lazarenkov, A
AU  - Morgades, M
AU  - Berbis, G
AU  - Ruíz-Xivillé, N
AU  - Gómez-Marzo, P
AU  - Ribera, J
AU  - Juncà, J
AU  - González-Pérez, A
AU  - Mercadal, S
AU  - Guardia, R
AU  - Artola, M T
AU  - Moreno, M J
AU  - Martínez-López, J
AU  - Zamora, L
AU  - Barba, P
AU  - Gil, C
AU  - Tormo, M
AU  - Cladera, A
AU  - Novo, A
AU  - Pratcorona, M
AU  - Nomdedeu, J
AU  - González-Campos, J
AU  - Almeida, M
AU  - Cervera, J
AU  - Montesinos, P
AU  - Batlle, M
AU  - Vives, S
AU  - Esteve, J
AU  - Feliu, E
AU  - Solé, F
AU  - Orfao, A
AU  - Ribera, J M
PY  - 2018
DO  - 10.1186/s13045-018-0639-8
UR  - http://hdl.handle.net/10668/12748
T2  - Journal of hematology & oncology
AB  - Recurrent deletions of the CDKN2A/ARF/CDKN2B genes encoded at chromosome 9p21 have been described in both pediatric and adult acute lymphoblastic leukemia (ALL), but their prognostic value remains controversial, with limited data on adult T-ALL. Here,...
LA  - en
KW  - CDKN2A/ARF
KW  - CDKN2B
KW  - MRD
KW  - Prognosis
KW  - T-ALL
KW  - Cyclin-Dependent Kinase Inhibitor p15
KW  - Cyclin-Dependent Kinase Inhibitor p16
KW  - Gene Deletion
KW  - Genes, p16
KW  - Humans
KW  - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
KW  - Prognosis
KW  - Tumor Suppressor Protein p14ARF
TI  - Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.
TY  - research article
VL  - 11
ER  -